Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-20

Clinical Trial Update: Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating sarecycline for efficacy and safety in patients with acute ischemic stroke after reperfusion therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sarecycline (sarecycline)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke, Acute | Phase 2 | Status: UNKNOWN